Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
NCT00689702
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
cetuximab, capecitabine
Sponsor
Institute of Oncology Ljubljana